Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Avanos Medical (AVNS) FCF Margin (2016 - 2025)

Avanos Medical (AVNS) has disclosed FCF Margin for 13 consecutive years, with 11.77% as the latest value for Q4 2025.

  • Quarterly FCF Margin fell 2458.0% to 11.77% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 6.15% through Dec 2025, down 768.0% year-over-year, with the annual reading at 6.15% for FY2025, 768.0% down from the prior year.
  • FCF Margin hit 11.77% in Q4 2025 for Avanos Medical, up from 3.94% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 175.42% in Q4 2021 to a low of 7.28% in Q1 2024.
  • Historically, FCF Margin has averaged 16.48% across 5 years, with a median of 11.54% in 2024.
  • Biggest five-year swings in FCF Margin: soared 16850bps in 2021 and later tumbled -15108bps in 2022.
  • Year by year, FCF Margin stood at 175.42% in 2021, then tumbled by -86bps to 24.34% in 2022, then crashed by -50bps to 12.23% in 2023, then soared by 197bps to 36.36% in 2024, then tumbled by -68bps to 11.77% in 2025.
  • Business Quant data shows FCF Margin for AVNS at 11.77% in Q4 2025, 3.94% in Q3 2025, and 2.4% in Q2 2025.